In its official response to the AMA’s recent call for a review of marijuana’s status as a Schedule I drug (barring any medical use) under federal law, the White House Office of National Drug Control Policy stated that it would defer to "the FDA's judgment that the raw marijuana plant cannot meet the standards for identity, strength, quality, purity, packaging and labeling required of medicine."

While we’re not used to factual accuracy from ONDCP, in this case they’re wrong not once, but twice.

First, there is absolutely no reason that plant medicines can’t be standardized and controlled for purity and potency. Indeed, the Netherlands has been doing just that for years, with medical marijuana distributed in Dutch pharmacies that is “of pharmaceutical quality and complies with the strictest requirements,” according to the Dutch government.

Second, the FDA has never said that a natural plant product can’t be a medicine. Indeed the agency has a lengthy “Guidance for Industry: Botanical Drug Products,” specifically designed to aid developers of plant medicines. The document not only doesn’t rule out plants as medicines, it even states, “In the initial stage of clinical studies of a botanical drug, it is generally not necessary to identify the active constituents or other biological markers or to have a chemical identification and assay for a particular constituent or marker.” Given that the active components of marijuana are already well-known and extensively researched, marijuana is well ahead of where the FDA says plant products need to be to start the process of seeking FDA licensing.

Yes, the FDA did put out a press release in 2006 saying that “smoked marijuana” had not been shown to be a safe and effective medicine. That statement was utterly unscientific, as we pointed out at the time, but it was absolutely not a declaration that the plant could never be a medicine.

The resignations keep piling on in Britain, weeks after that nation’s chief drug adviser, Prof. David Nutt, was fired for publicly criticizing several UK government drug policies, including a recent decision to strengthen marijuana penalties.

Today, three more members of the Advisory Council on the Misuse of Drugs were reported to have resigned in protest after they were unhappy with explanations offered by Home Secretary Alan Johnson, the man who demanded Nutt’s resignation. The resignations of Simon Campbell, Dr. Ian Ragan and John Marsden now bring to five the number of people on the once 31-member board who have left in protest since this saga began.

MPP Director of Government Relations Aaron Houston appears on Fox Freedom Watch to talk about the advances in marijuana policy and the failure of the drug war with Judge Andrew Napolitano. 11/09/2009

Big news: The American Medical Association adopted a new policy position today calling for the review of marijuana’s status as a Schedule I drug.

The revised policy "urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.” While it goes on to explain that the AMA is not stating support for state medical marijuana laws, the new policy does fall in line with what is quickly becoming a universal understanding in American medicine: Marijuana has undeniable medical uses and federal law should reflect that reality.

The new policy marks a historic shift from the AMA’s previous position, which recommended that “marijuana be retained in Schedule I,” grouping marijuana with drugs such as heroin, LSD, and PCP that are deemed to have no accepted medical uses.

The AMA’s previous position was often cited by medical marijuana opponents as evidence that the drug’s medical efficacy was in question. This new policy will go a long way to convincing politicians and policy makers that the compassionate use of medical marijuana should not be blocked by outdated marijuana laws.

There has long been reason to think that marijuana may be helpful to some patients with bipolar disorder, as certain cannabinoids have been shown in lab and animal studies to have effects that ought to be beneficial. Now, a new study from the University of Oslo finds that marijuana use is associated with better neurocognitive functioning in bipolar patients. In various tests of memory, learning, etc., bipolar patients who used marijuana did better than those who didn’t use it – the exact opposite of what the researchers found in patients with schizophrenia, a condition marijuana can sometimes worsen. “The findings,” the scientists write, “suggest that cannabis use may be related to improved neurocognition in bipolar disorder.”

That alcohol causes cancer isn’t really news, but how it does so hasn’t been fully understood. A new study, published in the journal Alcoholism: Clinical and Experimental Research, adds an important new piece of information. Alcohol, it turns out, stimulates a type of cell transformation that turns cancer cells more aggressive and thus more likely to spread throughout the body.

As we’ve noted before, research shows that cannabinoids (marijuana’s unique, active components) interfere with tumor growth and may actually prevent cancer.

Last night’s election produced two noteworthy victories for the marijuana policy reform movement.

In Maine, an estimated 58 percent of voters approved Question 5, making Maine the third state in the nation (along with Rhode Island and New Mexico) to establish state-licensed non-profit dispensaries that will provide medical marijuana to qualified patients. This is also significant because it is the first time such a system was enacted by voters. (The other two were approved by state legislatures.)

And in Colorado, more than 70 percent of voters in the tiny ski town of Breckenridge voted to remove city-level criminal penalties for possession of up to one ounce of marijuana for adults over 21. While possession of any amount is still illegal under state law, the citizens of Breckenridge have undoubtedly sent a message to lawmakers in Colorado—and around the country—by taking this first and necessary step toward the end of marijuana prohibition.

A frequent claim made by opponents of marijuana policy reform is that hardly anybody is ever really arrested for low-level marijuana offenses. But like most prohibitionist arguments, that's a lie.

In California, where marijuana possession was “decriminalized” in 1976 and medical marijuana legalized 20 years later, the state Department of Justice reports that law enforcement conducted a record 78,492 marijuana arrests in 2008. About 80% of these (61,366) were for mere possession – not sale or cultivation.

The California-based Center for Juvenile and Criminal Justice (CJCJ) took a long look at trends for marijuana arrests in the state and revealed some disturbing information. In its recent report to the California Legislature, CJCJ showed that the arrest rate for marijuana possession has skyrocketed in California – up 127% – between 1990 and 2008. But during the same period, arrests for all other offenses in California decreased by 40% – including other drug possession, which sank by nearly 30%. The arrest rate for marijuana sales and manufacturing even decreased 21% during this period.

You can’t help but conclude from this data that California’s police agencies have developed an almost singular focus on marijuana possession as their top law enforcement priority. This is shocking, not only because most Californians now say they want marijuana legal, but because it’s a dangerous and irresponsible use of limited public safety resources.

Last year, while California’s law enforcement officers were rounding up a record number of marijuana consumers, almost 60,000 reported violent crimes never resulted in an arrest.* Thanks to decriminalization in California, these arrests usually don't result in jail or lengthy detainment, but they do take real police time and other criminal justice resources.

Anyone unfortunate enough to have been a victim of an unsolved crime should support repealing marijuana prohibition and freeing up police to focus on public safety rather than consensual adult activity that's no more harmful than drinking beer or wine.

*Source: FBI, Crime in the U.S., 2008

Two members of Britain’s Advisory Council on the Misuse of Drugs have resigned in protest after the group’s chairman, Professor David Nutt, was fired last week for criticizing the UK government’s decision to strengthen penalties for marijuana offenses. Chemist Les King and pharmacist Marion Walker said that the government wrongly dismissed Nutt and violated his freedom of expression.

Several other advisers on the once 31-member group are rumored to be “planning collective action” against British Home Secretary Alan Johnson, who has taken to the airwaves to defend his controversial sacking of Nutt.

Johnson said Nutt publicly campaigned against government policy and “crossed the line” when he said illegal drugs such as marijuana, LSD, and ecstasy were safer than legal drugs such as tobacco and alcohol.

“Professor Nutt was not sacked for his views, which I respect but disagree with,” Johnson wrote in today’s Guardian.  “He was asked to go because he cannot be both a government adviser and a campaigner against government policy.”

It certainly is frustrating, to say the least, (“mind-boggling” might be a better word) when the people hired to reassess flawed government policies get punished for doing just that. But now that many high-profile members of Britain’s scientific community are speaking out about the incident, there is reason to hope that more Britons will realize just how misguided their current marijuana laws are, and that they too should support a change in the way the UK classifies certain drugs.

Nutt himself has continued to speak out about his ousting and the reasons behind it, arguing that his actions—as opposed to Johnson’s—were motivated by science, not politics.

In Nutt’s own words: “When [UK Prime Minister] Gordon Brown says that cannabis is a ‘lethal drug,’ when it clearly isn’t, young people are not going to pay him any notice. You don’t reduce drug harm by lying.”

Last week, I posted the results of the MPP-commissioned poll showing that despite outrageous claims being made by local officials, there is wide support for medical marijuana among Los Angeles County voters. A new poll now shows that support for medical marijuana access isn't confined to Los Angeles.

A poll released Wednesday in San Diego found super-majority support for medical marijuana in that city. The poll -- commissioned by addiction recovery Web site keepcomingback.com -- found 77% agreement that "officials must make sure that San Diego's medical marijuana patients have convenient access to their medicine in the city." 70% support regulating the city's medical marijuana collectives in some way, while only 9.5% support banning them (3% said they didn't need any regulations). The poll also collected other interesting information about how San Diegans view medical marijuana sales. Read more about it here.

This poll should send a firm message to San Diego County District Attorney Bonnie Dumanis, who just last month ordered a series of shocking raids on local medical marijuana patients and suppliers.